Dynamics of Mitochondrial Proteome and Acetylome in Glioblastoma Cells with Contrasting Metabolic Phenotypes
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Sirtuin 3 (SIRT3) regulates mitochondrial metabolism in glioblastoma. Inhibiting SIRT3 impacts protein synthesis and cell metabolism, revealing new therapeutic targets for this aggressive brain cancer.
Area Of Science
- Biochemistry
- Cell Biology
- Oncology
Background
- Glioblastoma is an aggressive brain cancer with poor prognosis.
- Mitochondrial metabolism is crucial for glioblastoma growth and progression.
- Sirtuin 3 (SIRT3) is a key regulator of mitochondrial enzyme acetylation and function.
Purpose Of The Study
- To investigate the role of SIRT3 in glioblastoma mitochondrial metabolism.
- To identify novel SIRT3 targets in glioblastoma cells.
- To compare proteomic and acetylomic profiles in glioblastoma cells with different metabolic phenotypes.
Main Methods
- Utilized high-resolution mass spectrometry.
- Analyzed proteome and acetylome of two glioblastoma cell lines.
- Inhibited SIRT3 activity chemically.
Main Results
- Lysine acetylation regulates protein synthesis machinery, influencing glioblastoma metabolic phenotype.
- Identified potential novel targets of SIRT3.
- Demonstrated differential proteomic and acetylomic responses based on metabolic phenotype.
Conclusions
- SIRT3 plays a critical role in regulating mitochondrial metabolism in glioblastoma.
- Targeting SIRT3 and its downstream pathways offers potential therapeutic strategies.
- Understanding SIRT3's function provides insights into glioblastoma energetics and progression.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
